US Broker Ratings

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 27.39% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is capturing investor attention with its robust growth trajectory and compelling potential upside of 27.39%, as indicated by current analyst ratings. As a leading..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is making waves in the biotechnology sector with its focus on developing therapies for autoimmune diseases. With a market capitalization of $2.09 billion, this Canadian..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Market with a 7.47% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG), a key player in the healthcare sector, specializes in health information services, offering innovative solutions for analyzing biological systems. Headquartered in Pleasanton, California, this life..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 10.73% Potential Upside Amidst Robust Revenue Growth

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing attention in the biotechnology sector with its promising developments in dermatological disease treatments. Headquartered in Westlake Village, California, this biopharmaceutical company is advancing..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Prescription for Growth with 9.75% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN), a prominent player in the healthcare sector, is gaining investor attention with its specialized services in medical care facilities across the United States. With..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 49.59% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is worth a close look by investors seeking opportunities in the medical care facilities industry. With a market capitalization..

Neogen Corporation (NEOG) Stock Analysis: Evaluating the 13% Upside Potential

Neogen Corporation (NASDAQ: NEOG) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Lansing, Michigan, Neogen has carved out a niche..

Evolent Health, Inc. (EVH) Stock Analysis: Evaluating a Promising 150% Potential Upside

Evolent Health, Inc. (NASDAQ: EVH) stands out in the healthcare sector, particularly within the health information services industry, as a company with a compelling narrative for investors seeking growth opportunities...

Vericel Corporation (VCEL) Stock Analysis: Exploring a 46% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a key player in the biotechnology sector, is drawing significant attention from investors, thanks to its robust product lineup and promising market position. Specializing in cellular..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 14% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) occupies a unique niche within the healthcare sector, focusing on the development and distribution of non-opioid pain management solutions. With a market capitalization of $1.17..

Clover Health Investments (CLOV): A 30% Upside Potential Amidst Revenue Growth and Market Volatility

Clover Health Investments, Corp. (NASDAQ: CLOV) is drawing attention in the healthcare sector with its notable 30.38% potential upside, as indicated by the average analyst target price of $3.23. Despite..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring a 9.25% Upside Potential in the Healthcare Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leader in the medical devices industry, is gaining attention from investors for its innovative approach to aesthetic and reconstructive plastic surgeries. With its..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering the 76.93% Upside Potential for Investors

Wave Life Sciences Ltd. (WVE), a pioneering biotechnology company headquartered in Singapore, is captivating the attention of investors with its promising 76.93% potential upside. As a key player in the..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 55% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc (NASDAQ: PLSE) is generating buzz among investors with its promising position in the healthcare sector. Specializing in medical instruments and supplies, this Miami-based company is making waves..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 18.38% Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, is gaining attention for its promising stock performance and growth potential. With a market cap of $1.25 billion,..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Promising 64.97% Upside Potential Draws Investor Attention

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology company based in Cambridge, Massachusetts, is gaining significant traction among investors due to its innovative approach to developing precision genetic medicines. With..

GRAIL, Inc. (GRAL) Investor Outlook: Exploring a Potential 19.48% Upside in the Healthcare Diagnostics Sector

GRAIL, Inc. (NASDAQ: GRAL) has been making waves in the healthcare diagnostics sector with its innovative approach to multi-cancer early detection. As a commercial-stage company, GRAIL is at the forefront..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: 55% Upside Potential Amidst Promising Drug Pipeline

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is carving out its niche in the biotechnology sector with a focus on muscle disorder therapies. With a market capitalization of $2.61 billion and a..

agilon health, inc. (AGL) Investor Outlook: Evaluating a 30.79% Potential Upside Amidst Challenging Valuations

agilon health, inc. (NYSE: AGL) is a company at the forefront of transforming healthcare delivery for seniors in the United States through its innovative platform that partners with primary care..

Enovis Corporation (ENOV) Stock Analysis: Exploring a 73.56% Potential Upside in Medical Devices

Enovis Corporation (NYSE: ENOV) has emerged as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.55 billion, Enovis is at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds